Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study

Abstract

The optimum regimen to treat severe nosocomial pneumonia was 2 g of meropenem infused over 3 h every 8 h. This regimen achieved the highest pharmacodynamic targets both in plasma and in ELF.